Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis

References

• Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun. 2022;132:1.
   Web of Science ®Google Scholar
• Weinmann-Menke J. [Lupus nephritis: from diagnosis to treatment]. Inn Med (Heidelb). 2023;64(3):225–10. doi: 10.1007/s00108-023-01489-y.
   PubMedGoogle Scholar
• Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7. doi: 10.1038/s41572-019-0141-9.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Amelio J, Gairy K, et al. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression. Lupus. 2020;29(9):1011–1020. doi: 10.1177/0961203320932219.
   PubMed Web of Science ®Google Scholar
• Renaudineau Y, Brooks W, Belliere J. Lupus nephritis risk factors and biomarkers: an update. Int J Mol Sci. 2023;24(19):14526. doi: 10.3390/ijms241914526.
   PubMed Web of Science ®Google Scholar
• Obrișcă B, Sorohan B, Tuță L, et al. Advances in lupus nephritis pathogenesis: from bench to bedside. Int J Mol Sci. 2021;22(7):3766. doi: 10.3390/ijms22073766.
   PubMed Web of Science ®Google Scholar
• Hsieh YP, Wen YK, Chen ML. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement. Clin Nephrol. 2012;77(1):18–24. doi: 10.5414/cn107094.
   PubMed Web of Science ®Google Scholar
• Mahmood SN, Mukhtar KN, Deen S, et al. Renal biopsy: a much needed tool in patients with systemic lupus erythematosis (SLE). Pak J Med Sci. 2016;32(1):70–74. doi: 10.12669/pjms.321.3386.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes T, Wilson HR, Morreale M, et al. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy. Kidney Int. 2017;92(5):1223–1231. doi: 10.1016/j.kint.2017.04.029.
   PubMed Web of Science ®Google Scholar
• Cristea A, Badea T, Bodizs G, et al. Antineutrophil cytoplasmic autoantibodies (ANCA)–markers in diagnosis and monitoring systemic vasculitides. Rom J Intern Med. 1995;33(1-2):37–46.
   PubMedGoogle Scholar
• Suwanchote S, Rachayon M, Rodsaward P, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin Rheumatol. 2018;37(4):875–884. doi: 10.1007/s10067-018-4062-x.
   PubMed Web of Science ®Google Scholar
• Weiner M, Segelmark M. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev. 2016;15(10):978–982. doi: 10.1016/j.autrev.2016.07.016.
   PubMed Web of Science ®Google Scholar
• Lacetera R, Calatroni M, Roggero L, et al. Prevalence and clinical significance of ANCA positivity in lupus nephritis: a case series of 116 patients and literature review. J Nephrol. 2023;36(4):1059–1070. doi: 10.1007/s40620-023-01574-3.
   PubMed Web of Science ®Google Scholar
• Yu F, Tan Y, Liu G, et al. Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int. 2009;76(3):307–317. doi: 10.1038/ki.2009.136.
   PubMed Web of Science ®Google Scholar
• Fauzi AR, Kong NC, Chua MK, et al. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med J Malaysia. 2004;59(3):372–377.
   PubMedGoogle Scholar
• Pyo JY, Jung SM, Song JJ, et al. ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis. Rheumatol Int. 2019;39(5):879–884. doi: 10.1007/s00296-019-04263-2.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725–1725. doi: 10.1002/art.1780400928.
   PubMed Web of Science ®Google Scholar
• Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the international society of nephrology/renal pathology society classification for lupus nephritis: clarification of definitions, and modified national institutes of health activity and chronicity indices. Kidney Int. 2018;93(4):789–796. doi: 10.1016/j.kint.2017.11.023.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–291.
   PubMed Web of Science ®Google Scholar
• Austin HA, 3rd, Boumpas DT, Vaughan EM, et al. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 1994;45(2):544–550. doi: 10.1038/ki.1994.70.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang X, Cai J, et al. Clinicopathologic characteristics and outcomes of lupus nephritis with antineutrophil cytoplasmic antibody: a retrospective study. Medicine (Baltimore). 2016;95(4):e2580.). doi: 10.1097/MD.0000000000002580.
   PubMed Web of Science ®Google Scholar
• Chin HJ, Ahn C, Lim CS, et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol. 2000;20(1):57–63. doi: 10.1159/000013557.
   PubMed Web of Science ®Google Scholar
• Pradhan VD, Badakere SS, Bichile LS, et al. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India. 2004;52:533–537.
   PubMedGoogle Scholar
• Pan HF, Fang XH, Wu GC, et al. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis. Inflammation. 2008;31(4):260–265. doi: 10.1007/s10753-008-9073-3.
   PubMed Web of Science ®Google Scholar
• Nishiya K, Chikazawa H, Nishimura S, et al. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol. 1997;16(1):70–75. doi: 10.1007/BF02238766.
   PubMed Web of Science ®Google Scholar
• Wang S, Shang J, Xiao J, et al. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody. Ren Fail. 2020;42(1):244–254.
   PubMed Web of Science ®Google Scholar
• Alforaih N, Whittall-Garcia L, Touma Z. A review of lupus nephritis. J Appl Lab Med. 2022;7(6):1450–1467. doi: 10.1093/jalm/jfac036.
   PubMedGoogle Scholar
• Yip J, Aghdassi E, Su J, et al. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(8):1667–1672. doi: 10.3899/jrheum.091028.
   PubMed Web of Science ®Google Scholar
• Hafez EA, Hassan SAE, Teama MAM, et al. Serum uric acid as a predictor for nephritis in egyptian patients with systemic lupus erythematosus. Lupus. 2021;30(3):378–384. doi: 10.1177/0961203320979042.
   PubMed Web of Science ®Google Scholar
• Parodis I, Tamirou F, Houssiau FA. Prediction of ­prognosis and renal outcome in lupus nephritis. Lupus Sci Med. 2020;7(1):e000389. doi: 10.1136/lupus-2020-000389.
   PubMed Web of Science ®Google Scholar
• Lamprecht P, Kerstein A, Klapa S, et al. Pathogenetic and clinical aspects of anti-Neutrophil cytoplasmic Autoantibody-Associated vasculitides. Front Immunol. 2018;9:680. doi: 10.3389/fimmu.2018.00680.
   PubMed Web of Science ®Google Scholar
• Morimoto S, Watanabe T, Lee S, et al. Improvement of rapidly progressive lupus nephritis associated MPO-ANCA with tacrolimus. Mod Rheumatol. 2010;20(3):291–294.
   PubMed Web of Science ®Google Scholar
• Nasr SH, D’Agati VD, Park HR, et al. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol. 2008;3(3):682–690. doi: 10.2215/CJN.04391007.
   PubMed Web of Science ®Google Scholar
• Li C, Zhou ML, Liang DD, et al. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study. BMJ Open. 2017;7(7):e015668. doi: 10.1136/bmjopen-2016-015668.
   PubMed Web of Science ®Google Scholar
• Fan Y, Kang D, Chen Z, et al. Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies. J Nephrol. 2023;36(8):2345–2354. doi: 10.1007/s40620-023-01622-y.
   PubMed Web of Science ®Google Scholar
• Tunnicliffe DJ, Palmer SC, Henderson L, et al. Immunosuppressive treatment for proliferative lupus nephritis. Cochrane Database Syst Rev. 2018;6(6):Cd002922.
   PubMedGoogle Scholar